ABVC BioPharma, Inc.

NasdaqCM:ABVC Stock Report

Market Cap: US$13.6m

ABVC BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.


Ownership Breakdown

What is the ownership structure of ABVC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies55.0580,523 %
Institutions110.1421,05 %
Individual Insiders3.678.22334,9 %
General Public6.690.44563,5 %

Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr erheblich verwässert, da die Zahl der ausstehenden Aktien um 122.7% gestiegen ist.


Top Shareholders

Top 25 shareholders own 36.49% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15,5 %
Shuling Jiang
1.628.464US$2.1m108 %no data
9,28 %
Eugene Jiang
977.072US$1.3m17,3 %no data
5,61 %
Tsung-Shann Jiang
590.843US$762.2k2.880 %no data
0,69 %
Uttam Patil
72.428US$93.4k0 %no data
0,55 %
Yoshinobu Odaira
57.758US$74.5k253 %no data
0,49 %
Leeds Chow
52.007US$67.1k19.000 %no data
0,48 %
LionGene Corporation
50.988US$65.8k0 %no data
0,46 %
Hsin-Hui Miao
48.072US$62.0k0 %no data
0,4 %
Chang-Jen Jiang
42.082US$54.3k9.050 %no data
0,4 %
Tsang Ming Jiang
41.994US$54.2k6.820 %no data
0,4 %
Yen-Hsin Chou
41.956US$54.1k7.270 %no data
0,4 %
Yu-Min Chung
41.943US$54.1k7.440 %no data
0,4 %
Norimi Sakamoto
41.854US$54.0k8.860 %no data
0,4 %
Che-Wei Hsu
41.723US$53.8k12.300 %no data
0,34 %
Renaissance Technologies LLC
36.100US$46.6k0 %no data
0,26 %
The Vanguard Group, Inc.
27.247US$35.1k48,7 %no data
0,26 %
Citadel Advisors LLC
27.158US$35.0k74,2 %no data
0,18 %
Geode Capital Management, LLC
19.480US$25.1k0 %no data
0,022 %
BioFirst Corporation
2.288US$3.0k0 %no data
0,0084 %
Genepro Investment Company
885US$1.1k0 %no data
0,0055 %
Tower Research Capital LLC
578US$746.0-80,6 %no data
0,0022 %
BioLite Inc.
228US$293.50 %no data
0,00095 %
Spotlight Asset Group, Inc.
100US$129.10 %no data
0,00086 %
Rgene Corporation
91US$116.90 %no data
0,00035 %
Royal Bank of Canada, Banking & Securities Investments
37US$47.60 %no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.